Serif Biomedicines
PrivateLast Round
Early Funding
Apr 21, 2026
Total Funding Raised
$50M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Serif Biomedicines operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was an Early Funding round in April 2026.
Serif Biomedicines is a biotechnology company pioneering Modified DNA as a new class of medicines, enabling programmable, scalable, durable, and redosable therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Serif Biomedicines Comparables
Compare Serif Biomedicines with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Code Biotherapeutics | 78% | |
| Tessera Therapeutics | 74% | |
| SYTE.bio | 74% |
For institutional investors. Book with your work email.
Serif Biomedicines Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Serif Biomedicines Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Flagship Pioneering | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 21, 2026
$50M raised in early funding round.
For institutional investors. Book with your work email.
Serif Biomedicines Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Serif Biomedicines's valuation, stock price, and market status.
Is Serif Biomedicines a public or private company?
Serif Biomedicines is a private company.
What is the current stock price of Serif Biomedicines?
Serif Biomedicines is a private company, so its shares have no public market price. Caplight tracks Serif Biomedicines's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Serif Biomedicines worth (valuation)?
Valuation information for Serif Biomedicines is not publicly available.
Can I buy Serif Biomedicines stock?
Serif Biomedicines shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Serif Biomedicines's last funding round?
Serif Biomedicines's most recent funding round was Early Funding on April 21, 2026.
Who are the main investors in Serif Biomedicines?
Key investors in Serif Biomedicines include Flagship Pioneering.
Will Serif Biomedicines IPO soon?
No public IPO plans have been announced for Serif Biomedicines.
How can I track Serif Biomedicines secondary market activity?
Caplight tracks bids, offers, and trades in Serif Biomedicines's shares on secondary markets.